1. Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study
   Yusuke Funakoshi et al, 2022, World Neurosurgery CrossRef
2. Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature
   Jennifer Jeck et al, 2018, Therapeutic Advances in Neurological Disorders CrossRef
3. The prognostic improvement of add-on bevacizumab for progressive disease during concomitant temozolomide and radiation therapy in patients with glioblastoma and anaplastic astrocytoma
   Shigeru YAMAGUCHI et al, 2021, Journal of Neurosurgical Sciences CrossRef
4. Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)
   Yusuke Funakoshi et al, 2021, International Journal of Clinical Oncology CrossRef
5. Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma
   Matthew C. Garrett et al, 2020, PLOS ONE CrossRef
6. Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma
   Yusuke Funakoshi et al, 2020, Pharmaceuticals CrossRef
7. First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide
   Nobuhiro Hata et al, 2020, Journal of Neuro-Oncology CrossRef
8. Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma
   Kosuke Takigawa et al, 2021, Journal of Neuro-Oncology CrossRef
9. Inducing a Transient Increase in Blood–Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme
   David J. Lundy et al, 2019, ACS Nano CrossRef
10. Long Noncoding RNA HOXA11-AS Functions as miRNA Sponge to Promote the Glioma Tumorigenesis Through Targeting miR-140-5p
    Yan Cui et al, 2017, DNA and Cell Biology CrossRef
11. Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic Approach
    Miguel Muñoz et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
12. Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system
    Hani M Babiker et al, 2018, Critical Reviews in Oncology/Hematology CrossRef
13. Timing of bevacizumab administration after biopsy for unresectable newly diagnosed glioblastoma
    Masahide Matsuda et al, 2022, Surgical Neurology International CrossRef